List of Excipients in API buprenorphine buccal
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing buprenorphine buccal
Detailed excipient profiles for buprenorphine buccal
Excipient focus: .ALPHA.-TOCOPHEROL ACETATE
buprenorphine buccal drug variants containing .ALPHA.-TOCOPHEROL ACETATE
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | buprenorphine buccal | 47781-471 |
| >Company | >Ingredient | >NDC |
buprenorphine buccal drug variants not containing .ALPHA.-TOCOPHEROL ACETATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: ANHYDROUS CITRIC ACID
buprenorphine buccal drug variants containing ANHYDROUS CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | buprenorphine buccal | 47781-471 |
| >Company | >Ingredient | >NDC |
buprenorphine buccal drug variants not containing ANHYDROUS CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CARBOXYMETHYLCELLULOSE SODIUM
buprenorphine buccal drug variants containing CARBOXYMETHYLCELLULOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | buprenorphine buccal | 47781-471 |
| >Company | >Ingredient | >NDC |
buprenorphine buccal drug variants not containing CARBOXYMETHYLCELLULOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
buprenorphine buccal drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | buprenorphine buccal | 47781-471 |
| >Company | >Ingredient | >NDC |
buprenorphine buccal drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
buprenorphine buccal drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | buprenorphine buccal | 47781-471 |
| >Company | >Ingredient | >NDC |
buprenorphine buccal drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYETHYL CELLULOSE
buprenorphine buccal drug variants containing HYDROXYETHYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | buprenorphine buccal | 47781-471 |
| >Company | >Ingredient | >NDC |
buprenorphine buccal drug variants not containing HYDROXYETHYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE
buprenorphine buccal drug variants containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | buprenorphine buccal | 47781-471 |
| >Company | >Ingredient | >NDC |
buprenorphine buccal drug variants not containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: METHYLPARABEN
buprenorphine buccal drug variants containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | buprenorphine buccal | 47781-471 |
| >Company | >Ingredient | >NDC |
buprenorphine buccal drug variants not containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PEPPERMINT OIL
buprenorphine buccal drug variants containing PEPPERMINT OIL
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | buprenorphine buccal | 47781-471 |
| >Company | >Ingredient | >NDC |
buprenorphine buccal drug variants not containing PEPPERMINT OIL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYCARBOPHIL
buprenorphine buccal drug variants containing POLYCARBOPHIL
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | buprenorphine buccal | 47781-471 |
| >Company | >Ingredient | >NDC |
buprenorphine buccal drug variants not containing POLYCARBOPHIL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
buprenorphine buccal drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | buprenorphine buccal | 47781-471 |
| >Company | >Ingredient | >NDC |
buprenorphine buccal drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLPARABEN
buprenorphine buccal drug variants containing PROPYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | buprenorphine buccal | 47781-471 |
| >Company | >Ingredient | >NDC |
buprenorphine buccal drug variants not containing PROPYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SACCHARIN SODIUM
buprenorphine buccal drug variants containing SACCHARIN SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | buprenorphine buccal | 47781-471 |
| >Company | >Ingredient | >NDC |
buprenorphine buccal drug variants not containing SACCHARIN SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SHELLAC
buprenorphine buccal drug variants containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | buprenorphine buccal | 47781-471 |
| >Company | >Ingredient | >NDC |
buprenorphine buccal drug variants not containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM BENZOATE
buprenorphine buccal drug variants containing SODIUM BENZOATE
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | buprenorphine buccal | 47781-471 |
| >Company | >Ingredient | >NDC |
buprenorphine buccal drug variants not containing SODIUM BENZOATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
buprenorphine buccal drug variants containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | buprenorphine buccal | 47781-471 |
| >Company | >Ingredient | >NDC |
buprenorphine buccal drug variants not containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS
buprenorphine buccal drug variants containing SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | buprenorphine buccal | 47781-471 |
| >Company | >Ingredient | >NDC |
buprenorphine buccal drug variants not containing SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
buprenorphine buccal drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | buprenorphine buccal | 47781-471 |
| >Company | >Ingredient | >NDC |
buprenorphine buccal drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
buprenorphine buccal drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | buprenorphine buccal | 47781-471 |
| >Company | >Ingredient | >NDC |
buprenorphine buccal drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
